Activation of NF-κB by FADD, Casper, and caspase-8

被引:258
作者
Hu, WH
Johnson, H
Shu, HB
机构
[1] Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA
[2] Peking Univ, Life Sci Coll, Beijing, Peoples R China
关键词
D O I
10.1074/jbc.275.15.10838
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fas-associated death domain protein (FADD), caspase-8-related protein (Casper), and caspase-8 are components of the tumor necrosis factor receptor type 1 (TNF-R1) and Fas signaling complexes that are involved in TNF-R1- and Fas-induced apoptosis. Here we show that overexpression of FADD and Gasper potently activates NF-kappa B, In the presence of caspase inhibitors, overexpression of caspase-8 also activates NF-kappa B. A caspase-inactive point mutant, caspase-8(C360S), activates NF-kappa B as potently as wild-type caspase-8, suggesting that caspase-8-induced apoptosis and NF-kappa B activation are uncoupled. NF-kappa B activation by FADD and Gasper is inhibited by the caspase-specific inhibitors crmA and BD-fmk, suggesting that FADD- and Gasper-induced NF-kappa B activation is mediated by caspase-8, FADD, Gasper, and caspase-8-induced NF-kappa B activation are inhibited by dominant negative mutants of TRAF2, NIK, I kappa B kinase alpha, and I kappa B kinase beta. A dominant negative mutant of RIP inhibits FADD- and caspase-8-induced but not Gasper-induced NF-kappa B activation. A mutant of Gasper and the caspase-specific inhibitors crmA and BD-fmk partially inhibit TNF-R1-, TRADD, and TNF-induced NF-kappa B activation, suggesting that FADD, Gasper, and caspase-8 function downstream of TRADD and contribute to TNF-R1-induced NF-kappa B activation. Moreover, activation of caspase-8 results in proteolytic processing of NIK, which is inhibited by crmA. When overexpressed, the processed fragments of NIK do not activate NF-kappa B, and the processed G-terminal fragment inhibits TNF-R1-induced NF-kappa B activation. These data indicate that FADD, Gasper, and pro-caspase-8 are parts of the TNF-R1-induced NF-kappa B activation pathways, whereas activated caspase-8 can negatively regulate TNF-R1-induced NF-kappa B activation by proteolytically inactivating NIK.
引用
收藏
页码:10838 / 10844
页数:7
相关论文
共 51 条
[1]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[2]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798
[3]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[4]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[5]  
Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961
[6]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554
[7]   CASH, a novel caspase homologue with death effector domains [J].
Goltsev, YV ;
Kovalenko, AV ;
Arnold, E ;
Varfolomeev, EE ;
Brodianskii, VM ;
Wallach, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19641-19644
[8]   THE TNF RECEPTOR 1-ASSOCIATED PROTEIN TRADD SIGNALS CELL-DEATH AND NF-KAPPA-B ACTIVATION [J].
HSU, HL ;
XIONG, J ;
GOEDDEL, DV .
CELL, 1995, 81 (04) :495-504
[9]   TNF-Dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex [J].
Hsu, HL ;
Huang, JN ;
Shu, HB ;
Baichwal, V ;
Goeddel, DV .
IMMUNITY, 1996, 4 (04) :387-396
[10]   TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways [J].
Hsu, HL ;
Shu, HB ;
Pan, MG ;
Goeddel, DV .
CELL, 1996, 84 (02) :299-308